Fred Aslan sold $260K of ARTV stock

Fred Aslan, Chief Executive Officer of Artiva Biotherapeutics, Inc. (ARTV), sold 62,178 shares of ARTV stock worth $260K, per an SEC Form 4 filed Nov 3, 2026.

It was an open-market sale.

The trade happened on Nov 2, 2026, 1 day before it was made public.

ARTV has moved +0.7% since the trade date, from $4.19 to $4.22 (Nov 9, 2026 close).